Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Mucosal Melanoma”

8 trials

Showing 8 of 8 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517653
What this trial is testing

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Who this might be right for
Melanoma
Shanghai Zhongshan Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT07336979
What this trial is testing

Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma

Who this might be right for
Resectable Mucosal Melanoma
Sun Yat-sen University 32
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT06999980
What this trial is testing

Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

Who this might be right for
Cutaneous MelanomaMucosal Melanoma
Melanoma Institute Australia 494
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353073
What this trial is testing

A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)

Who this might be right for
Head and Neck Mucosal Melanomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04622566
What this trial is testing

Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma

Who this might be right for
Mucosal MelanomaNeoadjuvant Treatment
Peking University Cancer Hospital & Institute 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03313206
What this trial is testing

Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma

Who this might be right for
Head and Neck Mucosal Melanomas
Gustave Roussy, Cancer Campus, Grand Paris 60
Testing effectiveness (Phase 2)Looking for participantsNCT07400302
What this trial is testing

Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery

Who this might be right for
Mucosal MelanomaPD-L1 Positive
The First Hospital of Jilin University 220

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation